On September 1, 2026, CMB International Financial Holdings Limited sold 1.15 million shares of Biocytogen Pharmaceuticals (02315) stock at an average of HKD 54.6372 per share, involving about HKD 62.75 million.
Prior to the disposal, CMB International Financial Holdings Limited's long position in Biocytogen Pharmaceuticals was 12.13 million shares, representing 10.95%; following the disposal, the holding changed to 10.98 million shares, with the long position ratio falling to 9.91%.